Opens in a new tab

DAST-10:
Scoring and Interpretation

The Drug Abuse Screening Test (DAST-10) is a 10-item yes or no screen for problems associated with drug use, generally excluding alcohol and tobacco. DAST-10 scoring hinges on one reverse-keyed item, so this guide sets out the keying, the 0 to 10 total, how to think about screening cutoffs and their published accuracy, SPSS and R code, and a model reporting paragraph.

ITEMS10
SUBSCALESNone
RESPONSE SCALEYes or no, item 3 reversed
SCORE RANGE0 to 10
DEVELOPEDSkinner, 1982

What the DAST-10 Measures

The DAST-10 assesses problems associated with drug use, generally excluding alcohol and tobacco. It is a brief screening instrument for health and behavioral research and not a count of substances consumed. The original Drug Abuse Screening Test was introduced by Skinner (1982), and Yudko et al. (2007) later reviewed the psychometric evidence across its 10-, 20- and 28-item forms.

A higher score means more endorsed drug-related problems. It does not identify which substance caused them, quantify dose, or diagnose a substance use disorder. When separate alcohol and other-drug risk profiles are needed, the DAST-10 is best used alongside other measures or a structured diagnostic interview.

Structure of the DAST-10

  • Items: ten yes or no items about consequences or difficulties associated with drug use over the time window the form specifies. Common clinical versions use the past 12 months, so verify the form your study administered.
  • Keying: in the NIDA DAST-10 version, item 3 is reverse-keyed, so the risk point is for No and not Yes. The other nine items score a point for Yes.
  • Subscales: none. The score is the count of ten keyed risk indicators, from 0 to 10.
  • Versions: the DAST-10, DAST-20 and original 28-item DAST are different forms. Score bands from one must not be applied to another.
  • Scope: record whether medication taken outside the prescribed directions is counted, following the form’s own instructions.
  • Translations: use a validated version for the intended population and name the language and its source. If no validated translation exists, say so and describe how the version was adapted.

The instrument itself is available from the US National Institute on Drug Abuse Clinical Trials Network data elements and is described in Skinner (1982).

How to Score the DAST-10

  1. Confirm that the ten variables follow the NIDA DAST-10 numbering and are coded Yes = 1 and No = 0.
  2. Reverse item 3 on this coding (keyed value = 1 minus the raw value), so that every variable shows 1 for a risk-indicating answer.
  3. Sum the ten keyed items to obtain dast10_total, which ranges from 0 to 10.
  4. Apply a missing-item rule set by the protocol. No developer-endorsed prorating rule was verified, so the code below requires all ten responses. A missing answer is not equivalent to no risk, so report how it was handled.
  5. If a screening threshold is used, state the validation sample and the outcome it was evaluated against.
SPSS SYNTAX

* Illustrative syntax: raw Yes = 1, No = 0, NIDA item order.
COMPUTE dast3_key = 1 - dast3.
COMPUTE dast10_total = SUM.10(dast1, dast2, dast3_key, dast4, dast5, dast6, dast7, dast8, dast9, dast10).
EXECUTE.
R

# data: one row per respondent; items dast1 to dast10 coded Yes = 1, No = 0.
items <- paste0("dast", 1:10)
stopifnot(all(vapply(data[items], function(x) all(is.na(x) | x %in% 0:1), logical(1))))
keyed <- data[items]
keyed$dast3 <- 1 - keyed$dast3
data$dast10_total <- rowSums(keyed, na.rm = FALSE)

Interpreting DAST-10 Scores

Score or category Interpretation
0 No endorsed risk indicators on the keyed items
1 to 10 An increasing number of endorsed drug-related problems
Screen-positive threshold Depends on purpose and validation population; no fixed value establishes a diagnosis

Source: Skinner (1982); Yudko et al. (2007); NIDA Clinical Trials Network DAST-10 scoring instructions.

Cutoffs trade sensitivity against specificity relative to a clinical reference standard. Yudko and colleagues documented variation in the diagnostic performance of the DAST forms across samples. Say why the chosen threshold suits your study and population instead of borrowing a score label from a general website.

The DAST-10 does not measure alcohol or tobacco misuse and does not establish a DSM diagnosis. Disclosures about substance use call for appropriate confidentiality protections.

Psychometric Properties

Property Published finding Source
Original design The DAST was introduced for substance-use screening and research; the original instrument was longer than the DAST-10 Skinner (1982)
Evidence overview A review covered the 10-, 20- and 28-item versions and found substantial variation across clinical settings Yudko et al. (2007)
Diagnostic accuracy Sensitivity and specificity vary by cutoff and sample, so no single figure should be generalized Yudko et al. (2007)
Item key The NIDA DAST-10 form reverses item 3 NIDA Clinical Trials Network (n.d.)
Short form DAST-10 totals are not numerically exchangeable with those of longer versions Yudko et al. (2007)

These are source-specific findings for a given population and version. They cannot be assumed to hold as reliability or accuracy estimates in a new sample.

Using the DAST-10 in a Study

In a cohort study, the 0 to 10 count can be modeled as a numeric or ordinal measure once its distribution and its relation to the outcome have been examined. In a screening study, compare the chosen cutoff with a specified diagnostic reference standard and report sensitivity and specificity with confidence intervals.

Record the response time frame and any substance exclusions, and check response patterns for missingness. When several substance categories or instruments are involved, define in advance which are primary, secondary or exploratory, to avoid post hoc threshold selection. State whether raw yes or no answers were keyed before summation and which questionnaire version was administered.

Reporting the DAST-10

Drug-related problems were screened with the 10-item Drug Abuse Screening Test (DAST-10; Skinner, 1982; Yudko et al., 2007). Ten yes or no responses were keyed according to the NIDA version, with item 3 reversed, and summed to a total (range = 0 to 10), with higher scores indicating more drug-related problems. The score was analyzed [continuously or at a prespecified cutoff], and missing responses were handled by [method].

References

National Institute on Drug Abuse, Clinical Trials Network. (n.d.). Drug Abuse Screening Test (DAST-10): Scoring instructions. National Institute on Drug Abuse.

Skinner, H. A. (1982). The drug abuse screening test. Addictive Behaviors, 7(4), 363-371. https://doi.org/10.1016/0306-4603(82)90005-3

Yudko, E., Lozhkina, O., & Fouts, A. (2007). A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. Journal of Substance Abuse Treatment, 32(2), 189-198. https://doi.org/10.1016/j.jsat.2006.08.002

Frequently Asked Questions

Yes, in the NIDA DAST-10 version with binary raw coding. Confirm the exact form and item numbering against the questionnaire you administered.

No. A screening score calls for follow-up assessment against recognized diagnostic criteria.

Not as a single validated scale, because they assess different substance-related constructs.

Do not read a missing answer as zero. Define a scoring and missing-data procedure before analysis and report it.

NEXT STEP

Need DAST-10 Data Scored
or Checked?

OnlineSPSS is a statistical consultancy for researchers. Share your design and dataset, and a statistically trained Research Coordinator reviews it. The scope and one fixed project fee are confirmed before work begins.

No Commitment Required

Strictly Confidential

Fixed Project Fee

In-House PhD-Level Statisticians

Same-Day Response

Serving Researchers Since 2014